The markets closed lower with the Dow tumbling 85 points to 23,348 as investors await details of the House GOP tax reform plan. Nasdaq slipped 2 points to 6,689.
On the upside
Stephen Cohen's Point72 Asset Management acquired more than 1.1 million shares of Adamas Pharmaceuticals (Nasdaq: ADMS).
Global Blood Therapeutics (Nasdaq: GBT) reported positive results from a case study involving a patient with sickle cell disease who was ineligible to participate in an ongoing Phase 3 HOPE study of voxelotor.
Acquisition rumors lifted shares of Mattel (Nasdaq: MAT).
On the downside
Walmart will not renew its license to distribute Iconix Brand Group's (Nasdaq: ICON) DanskinNow.
JPMorgan downgraded Office Depot (Nasdaq: ODP) from a Neutral rating to an Underweight rating.
JPMorgan downgraded Century Aluminum (Nasdaq: CENX) from an Overweight rating to a Neutral rating.
In the broad market, declining issues outpaced advancers by a margin of ore than 3 to 2 on the NYSE and by 2 to 1 on Nasdaq. The broader S&P 500 fell 8 points to 2,572. Bitcoin plummeted $84 to $6,093.